Astrazeneca Stock

• AstraZeneca forecasts 2022 growth even as COVID revenue wanes

  While sales of COVID-19 products are expected to decline by a low-to-mid 20s percentage this year, Astrazeneca forecast overall revenues to rise by a high teens percentage.

  Consumer

  Feb 10, 2022
  
• AstraZeneca says COVID-19 antibody drug 83% effective over six months

  AstraZeneca's treatment is given in one go, as two sequential shots in the arm.

  Health

  Nov 18, 2021
  
• Advertisement
• AstraZeneca’s coronavirus vaccine produces strong immune response in older adults

  The data suggests that those aged over 70, who are at higher risk of serious illness and death from COVID-19, could build robust immunity.

  Health

  Nov 19, 2020